CenExel AMRI

Toms River, United States Founded: 2013 • Age: 13 yrs Acquired By CenExel
Research and care for memory loss concerns are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors - Brand Intelligence

About CenExel AMRI

CenExel AMRI is a company based in Toms River (United States) founded in 2013 was acquired by CenExel in September 2021. It operates as a Professional Services. CenExel AMRI offers products and services including Clinical Trials for Alzheimer’s Disease, Vaccine Studies, and Healthy Volunteer Studies.

  • Headquarter Toms River, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Cenexel Clinical Research
Operational Areas
Healthcare → Healthcare Education, Research & Associations Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    CenExel

    (Sep 09, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CenExel AMRI

CenExel AMRI offers a comprehensive portfolio of products and services, including Clinical Trials for Alzheimer’s Disease, Vaccine Studies, and Healthy Volunteer Studies.

Product name locked
Category locked
Primary

Clinical trials for Alzheimer’s are conducted for research.

Product name locked
Category locked
Locked

Vaccine effects against viruses are evaluated through studies.

Product name locked
Category locked
Locked

Healthy volunteer trials are conducted for medical research.

Funding Insights of CenExel AMRI

Premium access

Detailed funding history for CenExel AMRI

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in CenExel AMRI

CenExel AMRI has secured backing from 1 investor. Prominent investors backing the company include CenExel.

All
Investor Description Founded Year Domain Location
Research site management and patient recruitment services are provided.
Locked Locked Locked
Premium access

Investor details for CenExel AMRI

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CenExel AMRI

Investments
Premium access

Investment portfolio details for CenExel AMRI

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - CenExel AMRI

Premium access

Detailed financials for CenExel AMRI

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cenexel Amri Comparisons

CenExel AMRI Primary company
Description
Research and care for memory loss concerns are provided.
Location
Toms River, United States
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for CenExel AMRI

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CenExel AMRI

Premium access

Detailed competitors of CenExel AMRI

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cenexel Amri

Premium access

Complete news archive for CenExel AMRI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CenExel AMRI

CenExel AMRI was founded in 2013.

CenExel AMRI is headquartered in Toms River, United States. It is registered at Toms River, New Jersey, United States.

Clinical research services are offered by CenExel AMRI, focusing on Alzheimers disease, dementia, and vaccine studies. Operations are conducted in the healthcare sector, with specialized trials for memory loss and cognitive impairments. Innovative medical treatments are provided through clinical trials overseen by board-certified physicians. A state-of-the-art facility in Toms River, United States, is maintained to ensure participant safety and comfort. Solutions for sponsors and CROs are also supported through a dedicated research network.

CenExel AMRI offers Clinical Trials for Alzheimer’s Disease, Vaccine Studies, and Healthy Volunteer Studies.

CenExel AMRI has 1 investor. Key investors include CenExel.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available